Erasmus Centre for Health Economics Rotterdam (EsCHER), Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
University of Rennes 1, Rennes, France.
Health Econ. 2022 Feb;31(2):382-398. doi: 10.1002/hec.4456. Epub 2021 Nov 18.
The interest in multivariate and higher-order risk preferences has increased. A growing body of literature has demonstrated the relevance and impact of these preferences, but for health the evidence is lacking. We measure multivariate and higher-order risk preferences for quality of life (QoL) and longevity, the two attributes of the Quality-Adjusted Life Year (QALY) model. We observe preferences for a positive correlation between these attributes and for pooling together a fixed loss in one of the attributes and a mean-zero risk in the other, and for pooling together mean-zero risks in QoL and longevity. The findings indicate that higher-order risk preferences are stronger for health than for money. Furthermore, we test if preferences for a risky treatment for a disease affecting only QoL, depend on life expectancy. We find no such a relation, but there is a positive relation between riskiness of a comorbidity affecting life expectancy and risk aversion for a QoL treatment. We therefore observe no definitive deviation from the QALY model, although the model is more robust when expected longevity is high. Our findings suggest that the current practice of cost-effectiveness analysis should be generalized to account for risk aversion in QoL and longevity, and higher-order preferences.
人们对多元和高阶风险偏好的兴趣日益浓厚。越来越多的文献证明了这些偏好的相关性和影响,但在健康领域,这方面的证据还很缺乏。我们衡量了生活质量 (QoL) 和长寿这两个质量调整生命年 (QALY) 模型属性的多元和高阶风险偏好。我们观察到人们对这两个属性之间存在正相关的偏好,以及对在一个属性中损失固定量并在另一个属性中获得均值为零的风险,以及对 QoL 和长寿中的均值为零的风险进行集中的偏好。研究结果表明,与金钱相比,人们对健康的高阶风险偏好更强。此外,我们还检验了仅影响 QoL 的疾病的风险治疗的偏好是否取决于预期寿命。我们没有发现这种关系,但在影响预期寿命的共病风险与对 QoL 治疗的风险厌恶之间存在正相关关系。因此,尽管当预期寿命较高时,模型更稳健,但我们没有观察到对 QALY 模型的明确偏离。我们的研究结果表明,目前的成本效益分析实践应推广到 QoL 和长寿以及高阶偏好的风险厌恶。